Found: 7
Select item for more details and to access through your institution.
Evidence-Based Recommendations for Education Provided to Patients and Families Regarding the Adverse Events of ALK and MEK Inhibitors: A Systematic Review From the Children's Oncology Group.
- Published in:
- Journal of Pediatric Hematology/Oncology Nursing, 2024, v. 41, n. 2, p. 114, doi. 10.1177/27527530231206101
- By:
- Publication type:
- Article
Sarcoid‐like reaction in a child following prolonged therapeutic exposure to dabrafenib and trametinib for BRAF V600E mutated hypothalamic/chiasmatic glioma.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 11, p. 1, doi. 10.1002/pbc.30619
- By:
- Publication type:
- Article
Neuropsychological impact of trametinib in pediatric low‐grade glioma: A case series.
- Published in:
- Pediatric Blood & Cancer, 2020, v. 67, n. 12, p. 1, doi. 10.1002/pbc.28690
- By:
- Publication type:
- Article
Profound clinical and radiological response to BRAF inhibition in a 2-month-old diencephalic child with hypothalamic/chiasmatic glioma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Impact of trametinib on the neuropsychological profile of NF1 patients.
- Published in:
- Journal of Neuro-Oncology, 2024, v. 167, n. 3, p. 447, doi. 10.1007/s11060-024-04624-3
- By:
- Publication type:
- Article
Time to dismiss boost? Outcomes of children with localized and metastatic germinoma.
- Published in:
- Journal of Neuro-Oncology, 2023, v. 162, n. 2, p. 443, doi. 10.1007/s11060-023-04307-5
- By:
- Publication type:
- Article
Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas.
- Published in:
- Current Oncology, 2024, v. 31, n. 7, p. 4022, doi. 10.3390/curroncol31070299
- By:
- Publication type:
- Article